跳至主要内容
临床试验/NCT00689572
NCT00689572已完成2 期

New Medication Treatment for Stimulant Dependence

University of Virginia1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
108
试验地点
1
主要终点
Cocaine Use by Self-report

研究概览

简要总结

This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.

详细描述

We propose to conduct a 9 week randomized, controlled clinical trial to evaluate the efficacy of ondansetron 4 mg twice daily compared with placebo (total N = 100/group × 2 groups = 200 individuals randomized, 400 total subjects will be consented), provided as an adjunct to manual-driven, structured CBT + BBCET in the treatment of cocaine dependence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females who have given written informed consent.
  • Ages 18 years and above and, must weigh at least 40 Kg and no more than 140 Kg.
  • Good physical health as determined by a complete physical examination, an EKG within normal limits, and laboratory screening tests within acceptable parameters.
  • Current DSM-IV diagnosis of cocaine dependence.
  • At least one positive urine drug screen for cocaine at screen or baseline prior to randomization.
  • The pregnancy test for females at intake must be negative.
  • Literacy in English and ability to read, understand, and complete the ratings scales and questionnaires accurately, follow instructions, and make use of the behavioral treatments.
  • Answered an advertisement in the newspaper/radio/television, and expressing a wish to stop using cocaine.
  • Willing to participate in behavioral treatments for cocaine dependence.

排除标准

  • Please contact site for additional information

研究组 & 干预措施

Ondansetron

Experimental

Ondansetron + Cognitive Behavioral Therapy + Brief Behavioral Enhancement Therapy

干预措施: Ondansetron (Drug)

Placebo

Placebo Comparator

Placebo + Cognitive Behavioral Therapy + Brief Behavioral Enhancement Therapy

干预措施: Placebo (Drug)

结局指标

主要结局

Cocaine Use by Self-report

时间窗: up to 9 weeks

Participants were assessed up to three times weekly for up to 9 weeks to evaluate cocaine use by self-report

Cocaine Use by Urine Benzoylecgonine

时间窗: up to 9 weeks

Urine samples were collected up to three times weekly for up to 9 weeks to test for the major cocaine metabolite benzoylecgonine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nassima Ait-Daoud Tiouririne

Associate Professor, Director of UVA Center for Addiction Research and Education

University of Virginia

研究点 (1)

Loading locations...

相似试验

New Medication Treatment for Stimulant Dependence | 临床试验